Susquehanna International Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.21B | Buy |
3,487,400
+87,800
| +3% | +$89M | 0.36% | 43 |
|
|
2025
Q4 | $3.65B | Sell |
3,399,600
-440,300
| -11% | -$421M | 0.42% | 43 |
|
|
2025
Q3 | $2.93B | Buy |
3,839,900
+723,200
| +23% | +$538M | 0.33% | 49 |
|
|
2025
Q2 | $2.43B | Buy |
3,116,700
+573,400
| +23% | +$446M | 0.34% | 46 |
|
|
2025
Q1 | $2.1B | Buy |
2,543,300
+67,800
| +3% | +$56.4M | 0.36% | 42 |
|
|
2024
Q4 | $1.91B | Buy |
2,475,500
+168,000
| +7% | +$139M | 0.29% | 50 |
|
|
2024
Q3 | $2.04B | Buy |
2,307,500
+347,900
| +18% | +$313M | 0.36% | 39 |
|
|
2024
Q2 | $1.77B | Buy |
1,959,600
+228,700
| +13% | +$183M | 0.33% | 45 |
|
|
2024
Q1 | $1.35B | Sell |
1,730,900
-211,600
| -11% | -$151M | 0.23% | 67 |
|
|
2023
Q4 | $1.13B | Buy |
1,942,500
+268,900
| +16% | +$157M | 0.22% | 62 |
|
|
2023
Q3 | $899M | Sell |
1,673,600
-163,400
| -9% | -$84.2M | 0.19% | 68 |
|
|
2023
Q2 | $862M | Sell |
1,837,000
-412,500
| -18% | -$173M | 0.18% | 66 |
|
|
2023
Q1 | $773M | Buy |
2,249,500
+300,200
| +15% | +$101M | 0.16% | 80 |
|
|
2022
Q4 | $713M | Buy |
1,949,300
+155,000
| +9% | +$55M | 0.18% | 82 |
|
|
2022
Q3 | $580M | Buy |
1,794,300
+498,700
| +38% | +$158M | 0.15% | 90 |
|
|
2022
Q2 | $420M | Buy |
1,295,600
+134,600
| +12% | +$40.4M | 0.1% | 141 |
|
|
2022
Q1 | $332M | Sell |
1,161,000
-602,500
| -34% | -$155M | 0.06% | 252 |
|
|
2021
Q4 | $487M | Sell |
1,763,500
-122,600
| -7% | -$31.1M | 0.07% | 211 |
|
|
2021
Q3 | $436M | Buy |
1,886,100
+264,900
| +16% | +$65.4M | 0.06% | 277 |
|
|
2021
Q2 | $372M | Buy |
1,621,200
+317,000
| +24% | +$63.7M | 0.05% | 298 |
|
|
2021
Q1 | $244M | Buy |
1,304,200
+469,700
| +56% | +$91.9M | 0.04% | 384 |
|
|
2020
Q4 | $141M | Sell |
834,500
-328,300
| -28% | -$49M | 0.02% | 532 |
|
|
2020
Q3 | $172M | Sell |
1,162,800
-143,300
| -11% | -$22.2M | 0.03% | 383 |
|
|
2020
Q2 | $214M | Buy |
1,306,100
+486,900
| +59% | +$74.7M | 0.05% | 284 |
|
|
2020
Q1 | $114M | Sell |
819,200
-104,700
| -11% | -$14.4M | 0.04% | 350 |
|
|
2019
Q4 | $121M | Buy |
923,900
+76,400
| +9% | +$8.86M | 0.04% | 415 |
|
|
2019
Q3 | $94.8M | Sell |
847,500
-344,500
| -29% | -$38.4M | 0.03% | 456 |
|
|
2019
Q2 | $132M | Sell |
1,192,000
-700
| -0.1% | -$82.4K | 0.05% | 328 |
|
|
2019
Q1 | $155M | Buy |
1,192,700
+218,800
| +22% | +$26.6M | 0.06% | 260 |
|
|
2018
Q4 | $113M | Sell |
973,900
-358,400
| -27% | -$40M | 0.04% | 344 |
|
|
2018
Q3 | $143M | Buy |
1,332,300
+751,900
| +130% | +$75.2M | 0.05% | 336 |
|
|
2018
Q2 | $49.5M | Sell |
580,400
-378,000
| -39% | -$31M | 0.02% | 685 |
|
|
2018
Q1 | $74.2M | Buy |
958,400
+133,800
| +16% | +$10.8M | 0.03% | 497 |
|
|
2017
Q4 | $69.6M | Sell |
824,600
-28,000
| -3% | -$2.38M | 0.02% | 554 |
|
|
2017
Q3 | $72.9M | Sell |
852,600
-741,200
| -47% | -$60.8M | 0.03% | 497 |
|
|
2017
Q2 | $131M | Buy |
1,593,800
+210,000
| +15% | +$17.1M | 0.06% | 276 |
|
|
2017
Q1 | $116M | Sell |
1,383,800
-1,329,700
| -49% | -$107M | 0.06% | 287 |
|
|
2016
Q4 | $200M | Buy |
2,713,500
+447,500
| +20% | +$33.3M | 0.1% | 173 |
|
|
2016
Q3 | $182M | Buy |
2,266,000
+366,900
| +19% | +$29.4M | 0.09% | 186 |
|
|
2016
Q2 | $150M | Buy |
1,899,100
+8,700
| +0.5% | +$655K | 0.08% | 207 |
|
|
2016
Q1 | $136M | Buy |
1,890,400
+41,900
| +2% | +$3.17M | 0.07% | 228 |
|
|
2015
Q4 | $156M | Sell |
1,848,500
-1,795,100
| -49% | -$149M | 0.07% | 234 |
|
|
2015
Q3 | $305M | Buy |
3,643,600
+1,759,500
| +93% | +$149M | 0.13% | 126 |
|
|
2015
Q2 | $157M | Buy |
1,884,100
+631,300
| +50% | +$48.1M | 0.07% | 261 |
|
|
2015
Q1 | $91M | Buy |
1,252,800
+23,600
| +2% | +$1.68M | 0.04% | 398 |
|
|
2014
Q4 | $84.8M | Buy |
1,229,200
+182,600
| +17% | +$12.3M | 0.03% | 471 |
|
|
2014
Q3 | $67.9M | Sell |
1,046,600
-195,500
| -16% | -$12.4M | 0.03% | 577 |
|
|
2014
Q2 | $77.2M | Sell |
1,242,100
-498,600
| -29% | -$29.7M | 0.03% | 480 |
|
|
2014
Q1 | $102M | Buy |
1,740,700
+137,700
| +9% | +$7.68M | 0.05% | 343 |
|
|
2013
Q4 | $81.8M | Sell |
1,603,000
-48,900
| -3% | -$2.45M | 0.04% | 424 |
|
|
2013
Q3 | $83.1M | Sell |
1,651,900
-106,300
| -6% | -$5.57M | 0.04% | 370 |
|
|
2013
Q2 | $86.4M | Buy |
+1,758,200
| New | +$95.7M | 0.05% | 312 |
|
Other funds holding LLY
VCM
VPM
Susquehanna International Group's LLY Position: Q1 2026 in Review
Susquehanna International Group reduced its Eli Lilly (LLY) stake by 35% in Q1 2026, selling an estimated $42.1M and leaving 78,552 shares worth $72.2M. The position accounts for 0.01% of the portfolio, ranked #1025.
Susquehanna International Group first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $383M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Susquehanna International Group held 78,552 shares of Eli Lilly worth $72.2M as of Q1 2026.
- Susquehanna International Group sold 41,523 Eli Lilly shares in Q1 2026, an estimated $42.1M.
- Eli Lilly made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1025 holding.
- Susquehanna International Group first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
- Susquehanna International Group's Eli Lilly position peaked at $383M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.